These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4336458)

  • 1. A challenge to the concept that ACTH affects growth hormone secretion in man.
    Byyny RL; Orth DN; Nicholson WE; Liddle GW
    J Clin Endocrinol Metab; 1972 Jun; 34(6):1093-6. PubMed ID: 4336458
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stimulation of growth hormones in children with ACTH].
    Girard J; Stahl M; Bühler U
    Schweiz Med Wochenschr; 1971 Jun; 101(25):930-2. PubMed ID: 4326529
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of metyrapone on secretion of growth hormone in man.
    Kunita H; Takebe K; Nakagawa K; Sawano S; Horiuchi Y
    J Clin Endocrinol Metab; 1970 Sep; 31(3):301-6. PubMed ID: 4318201
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous determinations of plasma ACTH and GH levels after an oral metyrapone.
    Sawano S; Saito T; Shizume K; Takebe K
    Endocrinol Jpn; 1972 Oct; 19(5):477-81. PubMed ID: 4346864
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of various ACTH preparations and of metyrapone on the secretion of growth hormone in normal subjects and in hypopituitary patients.
    Lee PA; Keenan BS; Migeon CJ; Blizzard RM
    J Clin Endocrinol Metab; 1973 Sep; 37(3):389-96. PubMed ID: 4361973
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous determination of cortisol, deoxycortisol and corticosterone in plasma and urine by competitive protein binding assay. Response of normal subjects to ACTH and metyrapone.
    Kolanowski J
    J Steroid Biochem; 1974 Feb; 5(1):55-64. PubMed ID: 4367584
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of ACTH response to oral and intravenous metyrapone by antiserotoninergic treatment in man.
    Cavagnini F; Panerai AE; Valentini F; Bulgheroni P; Peracchi M; Pinto M
    J Clin Endocrinol Metab; 1975 Jul; 41(1):143-8. PubMed ID: 168228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a single oral dose of metyrapone on secretion of growth hormone and urinary tetrahydro-11-deoxycortisol and tetrahydro-11-deoxycorticosterone excretion in children.
    Stahl M; Kapp JP; Zachmann M; Girard J
    Helv Paediatr Acta; 1972 Jun; 27(2):147-53. PubMed ID: 4644861
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimation of ACTH reserve on normal and hypopituitary subjects: comparison of oral and intravenous metyrapone with insulin hypoglycemia.
    Keenan BS; Beitins IZ; Lee PA; Kowarski A; Blizzard RM; Migeon CJ
    J Clin Endocrinol Metab; 1973 Oct; 37(4):540-9. PubMed ID: 4355091
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations of plasma levels of pituitary hormones after oral application of metyrapone.
    Schöneshöfer M; Fenner A
    Horm Metab Res; 1981 Aug; 13(8):473-4. PubMed ID: 6276285
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Sequential changes during oral and intravenous metyrapone administration.
    Jubiz W; Matsukura S; Meikle AW; Harada G; West CD; Tyler FH
    Arch Intern Med; 1970 Mar; 125(3):468-71. PubMed ID: 4313727
    [No Abstract]   [Full Text] [Related]  

  • 12. Extra-adrenal action of metyrapone upon human growth hormone secretion in man.
    Takahara J; Ogawa N; Ofuji T
    Endocrinol Jpn; 1972 Apr; 19(2):197-201. PubMed ID: 4341648
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of Corticotrophin and Somatototrophin by the Senescent Adenohypophysis in man.
    Blichert-Toft M
    Acta Endocrinol Suppl (Copenh); 1975; 78(195):15-154. PubMed ID: 166541
    [No Abstract]   [Full Text] [Related]  

  • 15. Extra-adrenal actions of metyrapone in man. Effects on plasma cortisol disappearance, growth hormone secretion and glucose metabolism.
    Bruno OD; Leclerq R; Virasoro E; Copinschi G
    J Clin Endocrinol Metab; 1971 Feb; 32(2):260-5. PubMed ID: 5099610
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of response of serum growth hormone to metyrapone.
    Sawin CT; Spark RF; Mitchell ML
    J Clin Endocrinol Metab; 1971 Jun; 32(6):854-6. PubMed ID: 4930786
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of metopirone on growth hormone, glycemia, and plasma insulin].
    Szöts F; Nadeau A; Tremblay R
    Union Med Can; 1973 Mar; 102(3):591-5. PubMed ID: 4351570
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of corticotrophin in promoting growth hormone release in man.
    Neri V; Bartorelli A; Ambrosi B; Beck-Peccoz P; Faglia G
    Folia Endocrinol; 1970 Oct; 23(5):513-9. PubMed ID: 4326106
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of intravenous injection of beta 1-24 corticotropin on somatotropin secretion].
    Thys C; Franchimont P
    C R Seances Soc Biol Fil; 1973; 167(11):1680-3. PubMed ID: 4371916
    [No Abstract]   [Full Text] [Related]  

  • 20. Low renin, "normal" aldosterone and hypertension: circadian rhythm of renin, aldosterone, cortisol and growth hormone.
    Grim C; Winnacker J; Peters T; Gilbert G
    J Clin Endocrinol Metab; 1974 Aug; 39(2):247-56. PubMed ID: 4371520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.